Literature DB >> 21122496

OCTN1 variant L503F is associated with familial and sporadic inflammatory bowel disease.

Zhenwu Lin1, Laurie Nelson, Andre Franke, Lisa Poritz, Tong-Yi Li, Rongling Wu, Yunhua Wang, Colin MacNeill, Neal J Thomas, Stefan Schreiber, Walter A Koltun.   

Abstract

PURPOSE: A two-allele haplotype of TC (OCTN1 rs1050152 and OCTN2 -207G→C) is associated with Crohn's disease (CD). The association has been replicated in different populations, but also failed in some studies. The present study is to replicate the association of OCTN1 rs1050152 and examine another variant rs272879 with familial and sporadic inflammatory bowel disease (IBD) in a cohort from central Pennsylvania, USA.
METHODS: The study samples (n=465) included 212 inflammatory bowel disease patients (CD=115, UC=97), including 103 familial (CD=55, UC=46) and 111 sporadic (CD=60, UC=51) IBD, 139 non-IBD family members from a familial IBD registry, and 114 unrelated healthy controls. A total of 12 OCTN1 variants within exonic sequences were examined. Two nonsynonymous SNPs, rs1050152 (L503F) and rs272879 (L395V) were genotyped by a PCR-based RFLP/cRFLP method and statistically analyzed. These samples with an additional 141 unrelated healthy samples were also genotyped for rs1050152 using the SNPlex™ Genotyping System.
RESULTS: The OCTN1 rs1050152 is associated with CD (OR=1.745, 95% CI=1.019-2.990, χ²=4.129, p=0.042) and with IBD (OR=1.68, 95% CI=1.052-2.676, χ²=4.732, p=0.030); while the variant rs272879 is not associated with IBD, CD or ulcerative colitis (UC). The distribution of the rs1050152 variant showed a high level of the T allele in male UC (OR=2.585, 95% CI=1.139-5.869, p=0.023) and IBD (OR=2.039, 95% CI=1.024-4.059, p=0.042) patients, and in female CD patients (OR=2.329, 95% CI=1.038-5.226, ρ value=0.039).
CONCLUSION: The present results replicated the association of the OCTN1 rs1050152 (L503F) variant with CD and IBD overall. A weak gender-specific effect of rs1050152 (L503F) on male UC and female CD was observed.
Copyright © 2009 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 21122496     DOI: 10.1016/j.crohns.2009.09.003

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  10 in total

Review 1.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  A model for family-based case-control studies of genetic imprinting and epistasis.

Authors:  Xin Li; Yihan Sui; Tian Liu; Jianxin Wang; Yongci Li; Zhenwu Lin; John Hegarty; Walter A Koltun; Zuoheng Wang; Rongling Wu
Journal:  Brief Bioinform       Date:  2013-07-24       Impact factor: 11.622

Review 3.  Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature.

Authors:  Patricia Sarlos; Erzsebet Kovesdi; Lili Magyari; Zsolt Banfai; Andras Szabo; Andras Javorhazy; Bela Melegh
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 4.  Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury.

Authors:  Eva Rath; Dirk Haller
Journal:  Mucosal Immunol       Date:  2022-05-09       Impact factor: 8.701

5.  Identification and Functional Characterization of Novel Genetic Variations in the OCTN1 Promoter.

Authors:  Hyo Jin Park; Ji Ha Choi
Journal:  Korean J Physiol Pharmacol       Date:  2014-04-03       Impact factor: 2.016

Review 6.  The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review.

Authors:  Dominika Jakubczyk; Katarzyna Leszczyńska; Sabina Górska
Journal:  Nutrients       Date:  2020-07-02       Impact factor: 5.717

Review 7.  Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.

Authors:  Dakota N Jackson; Arianne L Theiss
Journal:  Gut Microbes       Date:  2019-03-26

Review 8.  Organic Cation Transporters in the Lung-Current and Emerging (Patho)Physiological and Pharmacological Concepts.

Authors:  Mohammed Ali Selo; Johannes A Sake; Carsten Ehrhardt; Johanna J Salomon
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

Review 9.  Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs).

Authors:  Johanna Huttunen; Santosh Kumar Adla; Magdalena Markowicz-Piasecka; Kristiina M Huttunen
Journal:  Pharmaceutics       Date:  2022-06-10       Impact factor: 6.525

10.  The effect of turmeric (Curcuma longa) extract on the functionality of the solute carrier protein 22 A4 (SLC22A4) and interleukin-10 (IL-10) variants associated with inflammatory bowel disease.

Authors:  Mark J McCann; Sarah Johnston; Kerri Reilly; Xuejing Men; Elaine J Burgess; Nigel B Perry; Nicole C Roy
Journal:  Nutrients       Date:  2014-10-13       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.